Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
/in Acute Leukemia, International PublicationsCellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
/in Glioblastoma, International PublicationsDendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
/in Glioblastoma, International PublicationsThe role of hyperthermia in combined treatment in the management of soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue SarcomaInduction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells
/in Hepatocellular Carcinoma, International PublicationsDendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
/in International Publications, Pancreatic CancerTemperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed
/in Cervical Cancer, International PublicationsRestoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2)
/in Chronic Virus Hepatitis, International PublicationsDendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer